These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32771394)

  • 1. Targeted education as a method for reinforcing Paris System criteria and reducing urine cytology atypia rates.
    Compton ML; Weiss VL; Barkan GA; Ely KA
    J Am Soc Cytopathol; 2021; 10(1):9-13. PubMed ID: 32771394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Paris System "atypical urothelial cells" category: can the current criteria be improved?
    Vosoughi A; Ordobazari A; Lora Gonzalez MA; Guido LP; Skiba M; Campuzano-Zuluaga G; Kryvenko ON; Gomez-Fernandez C; Garcia-Buitrago M; Jorda M
    J Am Soc Cytopathol; 2021; 10(1):3-8. PubMed ID: 32732113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary tract cytology: a cytologic-histopathologic correlation with The Paris System, an institutional study.
    Danakas A; Sweeney M; Cheris S; Agrawal T
    J Am Soc Cytopathol; 2021; 10(1):56-63. PubMed ID: 33132054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Paris System for Reporting Urinary Cytology reduces atypia rates and does not alter the negative predictive value of urine cytology.
    McIntire PJ; Kilic I; Pambuccian SE; Wojcik EM; Barkan GA
    J Am Soc Cytopathol; 2021; 10(1):14-19. PubMed ID: 33221245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
    Pastorello RG; Barkan GA; Saieg M
    J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based diagnostic accuracy measurement in urine cytology using likelihood ratios.
    Myles N; Auger M; Kanber Y; Caglar D; Kassouf W; Brimo F
    J Am Soc Cytopathol; 2021; 10(1):71-78. PubMed ID: 33071190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
    Vlajnic T; Gut A; Savic S; Bubendorf L
    J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome analysis and negative predictive value of the "unsatisfactory/nondiagnostic" category of The Paris System for Reporting Urinary Cytology.
    Abro S; Nomani L; Wojcik EM; Pambuccian SE; Chatt G; Barkan GA
    J Am Soc Cytopathol; 2021; 10(1):64-70. PubMed ID: 33279453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An institutional experience evaluating hTERT immunostaining in 100 consecutive ThinPrep urine specimens.
    Xing J; Han M; Monaco SE; Dhir R; Roy S; Pantanowitz L
    J Am Soc Cytopathol; 2021; 10(1):88-93. PubMed ID: 32354607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying the Paris system for reporting urine cytology to challenging cytology cases.
    Glass R; Rosca O; Raab S; Szabelska J; Chau K; Sheikh-Fayyaz S; Cocker R
    Diagn Cytopathol; 2019 Jul; 47(7):675-681. PubMed ID: 31017746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell blocks in urine cytopathology: do they add value to the diagnosis? A pilot study.
    Wilson BL; Russell D; Evans SK; Agrawal T
    J Am Soc Cytopathol; 2021; 10(1):47-55. PubMed ID: 33039333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of urinary cytology in the setting of upper tract urothelial carcinoma.
    Zhang ML; VandenBussche CJ; Hang JF; Miki Y; McIntire PJ; Peyton S; Vohra P
    J Am Soc Cytopathol; 2021; 10(1):29-35. PubMed ID: 32792229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement.
    Reid MD; Osunkoya AO; Siddiqui MT; Looney SW
    Int J Clin Exp Pathol; 2012; 5(9):882-91. PubMed ID: 23119105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of upper urinary tract urine cytology before and after application of the Paris system.
    Simon CT; Skala SL; Magers MJ; Weizer A; Kaffenberger SD; Chinnaiyan AM; Spratt DE; Montgomery J; Mehra R; Lew M
    Diagn Cytopathol; 2019 May; 47(5):421-427. PubMed ID: 30569543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year study on the application of the Paris system for urinary cytology in a cancer centre.
    de Paula R; Oliveira A; Nunes W; Bovolim G; Domingos T; De Brot L; Bezerra S; Cunha I; Morini M; Saieg M
    Cytopathology; 2020 Jan; 31(1):41-46. PubMed ID: 31654587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in The Paris System for reporting urinary cytology?
    Suo L; Vega I; Thrall M
    J Am Soc Cytopathol; 2021; 10(1):20-24. PubMed ID: 32620533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade urothelial carcinoma with hypochromatic chromatin in urine cytology.
    Renshaw AA; Gould EW
    J Am Soc Cytopathol; 2021; 10(1):25-28. PubMed ID: 33132055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-grade urothelial carcinoma in urine cytology: different spaces - different faces, highlighting morphologic variance.
    McIntire PJ; Elsoukkary SS; Robinson BD; Siddiqui MT
    J Am Soc Cytopathol; 2021; 10(1):36-40. PubMed ID: 32958411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of false-negative for high-grade urothelial carcinoma in urine cytology.
    Lee PJ; Owens CL; Lithgow MY; Jiang Z; Fischer AH
    Diagn Cytopathol; 2016 Dec; 44(12):994-999. PubMed ID: 27781412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foreword: JASC urine cytology special edition.
    Wojcik EM; Pambuccian SE; Rosenthal DL
    J Am Soc Cytopathol; 2021; 10(1):1-2. PubMed ID: 33168474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.